ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance
A. Strillacci, P. Sansone, V. R. Rajasekhar, M. Turkekul, V. Boyko, F. Meng, B. Houck-Loomis, D. Brown, M. F. Berger, R. C. Hendrickson, Q. Chang, E. de Stanchina, F. Pareja, J. S. Reis-Filho, R. Segu Rajappachetty, , J. Bromberg
The paper identifies ER-LBD, a novel estrogen receptor alpha isoform, which promotes breast cancer growth and resistance to endocrine therapy.
bioRxiv · Oct 14, 2021 · PreprintCancer Biology